home *** CD-ROM | disk | FTP | other *** search
/ ftp.americansys.com / 2014.06.ftp.americansys.com.tar / ftp.americansys.com / plott / Practice.exe / 1033 / XSL / 4122 < prev   
Extensible Markup Language  |  2013-06-22  |  10KB  |  178 lines
  1. ∩╗┐<?xml version="1.0"?>
  2.  
  3. <xsl:stylesheet version="1.0"
  4. xmlns:xsl="http://www.w3.org/1999/XSL/Transform">
  5.  
  6.   <xsl:template match="/">
  7.     <html>
  8.       <head>
  9.         <title>PQRI Report</title>
  10.       </head>
  11.       <body>
  12.         File created on <xsl:value-of select="submission/file-audit-data/create-date"/> at <xsl:value-of select="submission/file-audit-data/create-time"/> by <xsl:value-of select="submission/file-audit-data/create-by"/>
  13.         <xsl:for-each select="submission/measure-group/provider">
  14.           <h2>
  15.             Measures for NPI <xsl:value-of select="npi"/>:
  16.           </h2>
  17.           <table border="1">
  18.             <tr bgcolor="#9acd32">
  19.               <th>PQRI #</th>
  20.               <th>NQF #</th>
  21.               <th>Measure</th>
  22.               <th>Eligible</th>
  23.               <th>Meeting Performance</th>
  24.               <th>Excluded From Performance</th>
  25.               <th>Performance Not Met</th>
  26.               <th>Reporting Rate</th>
  27.               <th>Performance Rate</th>
  28.             </tr>
  29.             <xsl:for-each select="pqri-measure">
  30.               <tr>
  31.                 <xsl:choose>
  32.                     <xsl:when test="pqri-measure-number='0038'">
  33.                       <td>N/A</td><td>0038</td><td>Childhood Immunization Status</td>
  34.                     </xsl:when>
  35.                     <xsl:when test="pqri-measure-number='12'">
  36.                       <td>12</td><td>0086</td><td>Primary Open Angle Glaucoma (POAG): Optic Nerve Evaluation</td>
  37.                     </xsl:when>
  38.                     <xsl:when test="pqri-measure-number='113'">
  39.                       <td>113</td><td>0034</td><td>Colorectal Cancer Screening</td>
  40.                     </xsl:when>
  41.                   <xsl:when test="pqri-measure-number='3'">
  42.                     <td>3</td><td>0061</td><td>Diabetes: Blood Pressure Management</td>
  43.                   </xsl:when>
  44.                   <xsl:when test="pqri-measure-number='0032'">
  45.                     <td>N/A</td><td>0032</td><td>Cervical Cancer Screening</td>
  46.                   </xsl:when>
  47.                   <xsl:when test="pqri-measure-number='111'">
  48.                     <td>111</td><td>0043</td><td>Preventive Care and Screening: Pneumonia Vaccination for Patients 65 Years and Older</td>
  49.                   </xsl:when>
  50.                   <xsl:when test="pqri-measure-number='110'">
  51.                     <td>110</td><td>N/A</td><td>Preventive Care and Screening: Influenza Immunization for Patients >= 50 Years Old</td>
  52.                   </xsl:when>
  53.                   <xsl:when test="pqri-measure-number='128-1'">
  54.                     <td>128-1</td><td>0421-1</td><td>Adult Weight Screening and Follow-Up - 1</td>
  55.                   </xsl:when>
  56.                   <xsl:when test="pqri-measure-number='128-2'">
  57.                     <td>128-2</td><td>0421-2</td><td>Adult Weight Screening and Follow-Up - 2</td>
  58.                   </xsl:when>
  59.                   <xsl:when test="pqri-measure-number='0013'">
  60.                     <td>N/A</td><td>0013</td><td>Hypertension: Blood Pressure Management</td>
  61.                   </xsl:when>
  62.                   <xsl:when test="pqri-measure-number='0028a'">
  63.                     <td>N/A</td><td>0028a</td><td>Preventive Care and Screening, pt. A - Tobacco Use Assessment</td>
  64.                   </xsl:when>
  65.                   <xsl:when test="pqri-measure-number='0028b'">
  66.                     <td>N/A</td><td>0028b</td><td>Preventive Care and Screening, pt. B - Tobacco Cessation Intervention</td>
  67.                   </xsl:when>
  68.                   <xsl:when test="pqri-measure-number='204'">
  69.                     <td>204</td><td>0068</td><td>Ischemic Vascular Disease (IVD): Use of aspirin or Another Antithrombotic</td>
  70.                   </xsl:when>
  71.                   <xsl:when test="pqri-measure-number='72'">
  72.                     <td>72</td><td>0385</td><td>Oncology Colon Cancer: Chemotherapy for Stage III Colon Cancer Patients</td>
  73.                   </xsl:when>
  74.                   <xsl:when test="pqri-measure-number='1'">
  75.                     <td>1</td><td>0059</td><td>Diabetes Mellitus: Hemoglobin A1c Poor Control in Diabetes Mellitus</td>
  76.                   </xsl:when>
  77.                   <xsl:when test="pqri-measure-number='8'">
  78.                     <td>8</td><td>0083</td><td>Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)</td>
  79.                   </xsl:when>
  80.                   <xsl:when test="pqri-measure-number='102'">
  81.                     <td>102</td><td>0389</td><td>Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low-Risk Prostate Cancer Patients</td>
  82.                   </xsl:when>
  83.                   <xsl:when test="pqri-measure-number='115a'">
  84.                     <td>115a</td><td>0027a</td><td>Preventive Care and Screening: Advising Smokers and Tobacco Users to Quit - A</td>
  85.                   </xsl:when>
  86.                   <xsl:when test="pqri-measure-number='115b'">
  87.                     <td>115b</td><td>0027b</td><td>Preventive Care and Screening: Advising Smokers and Tobacco Users to Quit - B</td>
  88.                   </xsl:when>
  89.                   <xsl:when test="pqri-measure-number='18'">
  90.                     <td>18</td><td>0088</td><td>Diabetic Retinopathy: Documentation of Presence or Absence of Macular Edema and Level of Severity of Retinopathy</td>
  91.                   </xsl:when>
  92.                   <xsl:when test="pqri-measure-number='6'">
  93.                     <td>6</td><td>0067</td><td>Coronary Artery Disease (CAD): Oral Antiplatelet Therapy Prescribed for Patients with CAD</td>
  94.                   </xsl:when>
  95.                   <xsl:when test="pqri-measure-number='5'">
  96.                     <td>5</td><td>0081</td><td>Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD)</td>
  97.                   </xsl:when>
  98.                   <xsl:when test="pqri-measure-number='64'">
  99.                     <td>64</td><td>0001</td><td>Asthma Assessment</td>
  100.                   </xsl:when>
  101.                   <xsl:when test="pqri-measure-number='7'">
  102.                     <td>7</td><td>0070</td><td>Coronary Artery Disease (CAD): Beta-Blocker Therapy for CAD Patients with Prior Myocardial Infarction (MI)</td>
  103.                   </xsl:when>
  104.                   <xsl:when test="pqri-measure-number='71'">
  105.                     <td>71</td><td>0387</td><td>Oncology Breast Cancer: Hormonal Therapy for Stage IC-IIIC Estrogen Receptor/Progesterone Receptor (ER/PR) Positive Breast Cancer</td>
  106.                   </xsl:when>
  107.                   <xsl:when test="pqri-measure-number='19'">
  108.                     <td>19</td><td>0089</td><td>Diabetic Retinopathy: Communication with the Physician Managing Ongoing Diabetes Care</td>
  109.                   </xsl:when>
  110.                   <xsl:when test="pqri-measure-number='197'">
  111.                     <td>197</td><td>0074</td><td>Coronary Artery Disease (CAD): Drug Therapy for Lowering LDL-Cholesterol</td>
  112.                   </xsl:when>
  113.                   <xsl:when test="pqri-measure-number='201'">
  114.                     <td>201</td><td>0073</td><td>Ischemic Vascular Disease (IVD): Blood Pressure Management</td>
  115.                   </xsl:when>
  116.                   <xsl:when test="pqri-measure-number='2'">
  117.                     <td>2</td><td>0064</td><td>Diabetes: Low Density Lipoprotein (LDL) Management and Control</td>
  118.                   </xsl:when>
  119.                   <xsl:when test="pqri-measure-number='119'">
  120.                     <td>119</td><td>0062</td><td>Diabetes: Urine Screening</td>
  121.                   </xsl:when>
  122.                   <xsl:when test="pqri-measure-number='112'">
  123.                     <td>112</td><td>0031</td><td>Preventive Care and Screening: Screening Mammography</td>
  124.                   </xsl:when>
  125.                   <xsl:when test="pqri-measure-number='163'">
  126.                     <td>163</td><td>0056</td><td>Diabetes Mellitus: Foot Exam</td>
  127.                   </xsl:when>
  128.                   <xsl:when test="pqri-measure-number='117'">
  129.                     <td>117</td><td>0055</td><td>Diabetes Mellitus: Dilated Eye Exam in Diabetic Patient</td>
  130.                   </xsl:when>
  131.                   <xsl:when test="pqri-measure-number='200'">
  132.                     <td>200</td><td>0084</td><td>Heart Failure: Warfarin Therapy for Patients with Atrial Fibrillation</td>
  133.                   </xsl:when>
  134.                   <xsl:when test="pqri-measure-number='0024'">
  135.                     <td>N/A</td><td>0024</td><td>Weight Assessment and Counseling for Children and Adolescents</td>
  136.                   </xsl:when>
  137.                     <xsl:otherwise>
  138.                       <td></td>
  139.                       <td></td>
  140.                       <td>
  141.                         <xsl:value-of select="pqri-measure-number"/>
  142.                       </td>
  143.                     </xsl:otherwise>
  144.                   </xsl:choose>                  
  145.                 <td>
  146.                   <xsl:value-of select="eligible-instances"/>
  147.                 </td>
  148.                 <td>
  149.                   <xsl:value-of select="meets-performance-instances"/>
  150.                 </td>
  151.                 <td>
  152.                   <xsl:value-of select="performance-exclusion-instances"/>
  153.                 </td>
  154.                 <td>
  155.                   <xsl:value-of select="performance-not-met-instances"/>
  156.                 </td>
  157.                 <td>
  158.                   <xsl:value-of select="reporting-rate"/>
  159.                 </td>
  160.                 <td>
  161.                   <xsl:choose>
  162.                     <xsl:when test="performance-rate=''">
  163.                       N/A
  164.                     </xsl:when>
  165.                     <xsl:otherwise>
  166.                       <xsl:value-of select="performance-rate"/>
  167.                     </xsl:otherwise>
  168.                   </xsl:choose>                  
  169.                 </td>
  170.               </tr>
  171.             </xsl:for-each>
  172.           </table>
  173.         </xsl:for-each>
  174.       </body>
  175.     </html>
  176.   </xsl:template>
  177.  
  178. </xsl:stylesheet>